A pivotal trial of IMM-1-104 in combination with modified gemcitabine or nab-paclitaxel in patients with solid tumors
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs IMM 1 104 (Primary) ; Gemcitabine; Paclitaxel
- Indications Solid tumours
- Focus Therapeutic Use
- 20 Jan 2025 New trial record